CD14 and cancer: Moreover, we demonstrated that CD14+ cells isolated from PDAC patients have a distinctive gene signature as compared to the monocytes isolated from HD suggesting that, during cancer progression, monocytes activate specific transcriptional programs that can be, in turn, used as potential biomarkers.